UBS Maintains Neutral on Eastman Chemical, Raises Price Target to $91
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has maintained a Neutral rating on Eastman Chemical (NYSE:EMN) and increased the price target from $89 to $91.
January 11, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has maintained a Neutral rating on Eastman Chemical and raised the price target from $89 to $91, indicating a potential upside from the previous target.
The increase in price target by UBS suggests a positive outlook on the stock's value, which could lead to a short-term increase in investor confidence and potentially a rise in the stock price. However, since the rating remains Neutral, the impact may be moderate rather than significant.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100